4-6 October
Basel, Switzerland
Meet us on booth 406
See our keynote talk in the AI in Drug Development track
PrecisionLife CEO, Steve Gardner, presents A New Era of Precision Neuroscience at BioTechX in the AI in Drug Development track at 12:45pm on Day 1.
Steve will be joined by Chief Business and Investment Officer, Rowan Gardner and Senior Portfolio Manager Krystyna Taylor at the event.
You can meet the PrecisionLife team on Booth #406 and in the networking zone throughout the meeting.
We will also be presenting a poster on Precision Medicine for Alzheimer’s Disease: Identifying Effective Therapeutic Strategies with Patient Stratification Biomarkers, from 10:50 – 11:40 on Thursday 5th October.
PrecisionLife is a leading computational biology company achieving the deepest understanding of disease biology and mechanistic patient stratification, mapping causative disease biology to patient subgroups to enable precision medicine in complex chronic diseases. Our approach yields better target selection, decreased drug development risk, accelerated regulatory approval, and enhanced market adoption of precision-targeted therapies for their biopharma partners.
Send us a message to meet with us and discuss opportunities to collaborate.
For further information about the event, visit the BioTechX website.
